title: Neuroendocrine tumours of the upper gastrointestinal tract and pancreas.
abstract: Neuroendocrine tumours of upper gastrointestinal tract fall into two main categories. First carcinoid tumours of the stomach and duodenum and secondly endocrine pancreatic tumours. The endocrine tumours of the gastric mucosa include two main types, so called ECL-oma of the corpus and fundic region and gastrin producing carcinoids or hyperplasia of the antrum and duodenum. The endocrine tumours of pancreas include entopically secreting insulinomas, glucagonomas, somatostatinomas, PP-omas, and ectopically secreting tumours, such as gastrinomas and tumours producing ACTH, GHRH, and calcitonin. The diagnosis of a neuroendocrine tumour of the upper gastrointestinal tract is based on the recognition of certain clinical syndromes and the determination of certain humoral products. A broad battery of radioimmunological assays for determination of different peptides is mandatory for the diagnosis and follow up of these patients. The diagnosis is also based on histological and immunocytochemical investigation of tissue specimens obtained at operation or by biopsy. Ultrasound investigation is the best non-invasive technique to detect metastases from neuroendocrine gut and pancreatic tumours, but angiography might unveil metastases down to a size of less than 5 mm. Surgery is still the primary treatment procedure but other treatments are needed because many patients have metastases already at the time of diagnosis. Chemotherapy with streptozocin combined with 5-fluorouracil or adriamycin and human leucocyte interferon has demonstrated objective response rate of about 70%. The new somatostatin analogue SMS 201-995 is an important adjunct in controlling clinical symptoms in patients with neuroendocrine gut and pancreatic tumours. A combination of different treatment procedures is needed for long-term management of these patients.
authors.affiliation: Department of Medicine, Akademiska Sjukhuset, Uppsala, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Oberg
authors.forename: B
authors.initials: B
authors.lastname: Eriksson
authors.forename: M
authors.initials: M
authors.lastname: Lundqvist
mesh_terms: D002276:Carcinoid Tumor / Q000503:physiopathology*; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000503:physiopathology* / Q000601:surgery; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery; D013577:Syndrome